myHelsana - Apps on Google Play
Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C | PLOS ONE
Continuity of Care in Swiss Cancer Patients Using Claims Data | PPA
DescTools <preliminary blueprint version>
Helsana Krankenkasse Beratung - Innovativ und unverbindlich
Medical Insurance for Fermilab Users with J-1 Visas
Reports and Research
BASIS: das Standardmodell der Grundversicherung - Helsana
INTERNATIONAL INSURANCE FACT BOOK 2005
Untitled
IJERPH | Free Full-Text | Recording of Chronic Diseases and Adverse Obstetric Outcomes during Hospitalizations for a Delivery in the National Swiss Hospital Medical Statistics Dataset between 2012 and 2018: An Observational
Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study | PLOS ONE
dok seminar presentation
myHelsana by Helsana Versicherungen AG
Can I lose weight solely by going on a diet? - Helsana
Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes
PDF) Hospital readmission risk prediction based on claims data available at admission: a pilot study in Switzerland
Breakthrough: Strengthening Mutual Caring and Sharing | SpringerLink
World 2022
BeneFit PLUS: the general practitioner model - Helsana
Full article: Anti-VEGF treatment patterns and associated health care costs in Switzerland: findings using real-world claims data
IJERPH | Free Full-Text | Characteristics of Presentations to the Emergency Department Following Attempted Suicide with Drugs
BASIS: the standard model under basic insurance - Helsana
BeneFit PLUS: the general practitioner model - Helsana
Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database - Huber - 2020 - Pharmacoepidemiology and Drug Safety - Wiley Online ...
myHelsana on the App Store
